About 1.8 million people in the country are waiting for the second dose of the Oxford-Astrageneca ticker (Covishield). The government is trying desperately to get them vaccinated. In this case, there is no trust from any country other than the United States. The United States has the AstraZeneca vaccine. The Biden administration recently announced that it would release 60 million doses of the AstraZeneca vaccine and 20 million doses of other vaccines to the world. The United States is giving about 20 million doses of vaccine this June. However, the United States will provide 75 percent of those doses through Covax. In such a context, Bangladesh is looking to the United States to tackle its deficit. The White House has already announced that the United States will provide 6 million doses of vaccine to 16 countries, including Bangladesh.
In such a situation, the foreign minister said. AK Abdul Momen is going to visit the United States next week. The purpose of his visit is to attend a discussion on the Rohingya in New York and a meeting of the Least Developed Countries (LDCs). At the LDC meeting, he will seek vaccinations for the least developed countries, including Bangladesh.
Foreign Minister. Momen said Bangladesh has asked the United States for 2 million doses of the estrogen vaccine. Expatriate Bangladeshis including the US Embassy in Bangladesh and the Bangladesh Embassy in the United States are also continuing their efforts.
It is known that the United States Secretary of State Anthony Blinken. Attempts are being made to arrange a meeting for Momen. A source said the US Food and Drug Administration (FDA) has not yet approved the use of the estrogen vaccine in that country. As a result, there are complications in the export of the vaccine. Therefore, it is relatively easy to export FDA-approved vaccines such as Pfizer and Modern vaccines. The United States has contacted Bangladesh about bilateral exports of the vaccines. However, the foreign minister said talks were underway with the United States on all vaccines for Kavid. The United States has said it will vaccinate Bangladesh. However, the United States has not yet decided how much.
Meanwhile, after a US aid consignment arrived in Bangladesh on Monday, another consignment left for Bangladesh on Wednesday. US Secretary of Defense Lloyd J. Austin said in a tweet that this year’s shipment contained other materials, including PPE, to combat cavities.
Relevant sources say another 600,000 synoform vaccines could be obtained from China by next week. In addition, attempts are being made to get vaccines commercially from China and Russia. In this case, the work is moving forward. But the government’s main concern now is to ensure a second dose of the 1.7 million AstraZeneca vaccine.
On the other hand, there is uncertainty about the timely availability of vaccines from the ‘Kavid-17 Vaccines Global Access (COVAX)’ initiative. According to diplomatic sources, one lakh 720 doses of Pfizer-Bioentech vaccine were allocated for Bangladesh under CoVAX. The vaccine was delivered to Bangladesh in the first week of this month. Covax has allocated one crore 9 lakh eight thousand doses of Serum-Astrageneca (Kavishield) vaccine for Bangladesh. But so far not a single dose has been delivered.
The Serum Institute of India (SII) said in May that it could start supplying vaccines to Kovacs and other countries by the end of this year. In other words, if the Oxford-Astrageneca vaccine (Covishield) is not given to Serum Institute Covax, the availability of Covishield vaccine in Bangladesh will be uncertain. In this case, the temporary crisis could be alleviated if the United States provided the stockpile of AstraZeneca vaccine. The United States invested about প্রায় 1 billion in the Oxford-AstraZeneca vaccine effort last year, and ordered the supply of 300 million doses of the vaccine after the vaccine was invented.